JP2022519500A5 - - Google Patents

Info

Publication number
JP2022519500A5
JP2022519500A5 JP2021544218A JP2021544218A JP2022519500A5 JP 2022519500 A5 JP2022519500 A5 JP 2022519500A5 JP 2021544218 A JP2021544218 A JP 2021544218A JP 2021544218 A JP2021544218 A JP 2021544218A JP 2022519500 A5 JP2022519500 A5 JP 2022519500A5
Authority
JP
Japan
Prior art keywords
composition according
bone
fungal
hydrate
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021544218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022519500A (ja
JP7562542B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/015948 external-priority patent/WO2020160316A1/en
Publication of JP2022519500A publication Critical patent/JP2022519500A/ja
Publication of JP2022519500A5 publication Critical patent/JP2022519500A5/ja
Application granted granted Critical
Publication of JP7562542B2 publication Critical patent/JP7562542B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021544218A 2019-01-30 2020-01-30 真菌性骨-関節感染症を治療するためのトリテルペノイド系抗真菌薬 Active JP7562542B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962798743P 2019-01-30 2019-01-30
US62/798,743 2019-01-30
PCT/US2020/015948 WO2020160316A1 (en) 2019-01-30 2020-01-30 Triterpenoid antifungals for the treatment of fungal osteo-articular infections

Publications (3)

Publication Number Publication Date
JP2022519500A JP2022519500A (ja) 2022-03-24
JP2022519500A5 true JP2022519500A5 (cg-RX-API-DMAC7.html) 2023-04-10
JP7562542B2 JP7562542B2 (ja) 2024-10-07

Family

ID=69740705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021544218A Active JP7562542B2 (ja) 2019-01-30 2020-01-30 真菌性骨-関節感染症を治療するためのトリテルペノイド系抗真菌薬

Country Status (7)

Country Link
US (2) US20220117948A1 (cg-RX-API-DMAC7.html)
EP (1) EP3917534B1 (cg-RX-API-DMAC7.html)
JP (1) JP7562542B2 (cg-RX-API-DMAC7.html)
CN (1) CN113498343A (cg-RX-API-DMAC7.html)
EA (1) EA202192107A1 (cg-RX-API-DMAC7.html)
MA (1) MA54866A (cg-RX-API-DMAC7.html)
WO (1) WO2020160316A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020276595B2 (en) * 2019-05-16 2025-12-04 Scynexis, Inc. Antifungal Agents for Candida Auris Decolonization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) * 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
BRPI0912074B1 (pt) * 2008-08-12 2021-08-03 Merck Sharp & Dohme Corp Composto e composição farmacêutica
US20210002346A1 (en) * 2016-11-29 2021-01-07 Cidara Therapeutics, Inc Methods for preventing fungal infections

Similar Documents

Publication Publication Date Title
JP2021063088A5 (cg-RX-API-DMAC7.html)
JP2023030113A5 (cg-RX-API-DMAC7.html)
US20040157773A1 (en) Farnesyl protein transferase inhibitors for treating cachexia
US20230364067A1 (en) Antifungal agents with enhanced activity in acidic ph
JP2023537921A5 (cg-RX-API-DMAC7.html)
EP1879654B1 (fr) Combinaison pharmaceutique comprenant un agent antifongique et un actif qui est notamment l'eugénol ou le carvacrol
HU224920B1 (en) Use of an antifungal composition
JP2020513037A5 (cg-RX-API-DMAC7.html)
JP2020529999A5 (cg-RX-API-DMAC7.html)
CN101301289A (zh) 小檗碱及其结构类似物在逆转多药耐药泵中的应用
JP2025509278A5 (cg-RX-API-DMAC7.html)
EP4698164A1 (en) Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof
JP7562542B2 (ja) 真菌性骨-関節感染症を治療するためのトリテルペノイド系抗真菌薬
JP2022523212A5 (cg-RX-API-DMAC7.html)
TWI881977B (zh) 用於消除耳念珠菌移生之抗真菌劑
JP2022532734A5 (cg-RX-API-DMAC7.html)
JP2021508728A5 (cg-RX-API-DMAC7.html)
JP7581219B2 (ja) ニューモシスチス属種(Pneumocystis spp.)肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬
HK40062347A (en) Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia
JP2005507884A5 (cg-RX-API-DMAC7.html)
HK40067174A (en) Antifungal agents, like ibrexafungerp for candida auris decolonization
EA047126B1 (ru) Противогрибковое средство для лечения или профилактики инфекции вульвовагинального кандидоза
HK40030410B (en) Antifungal agents with enhanced activity in acidic ph